Sanofi India, Emcure Pharma forge exclusive partnership for cardiovascular product distribution Ruchika Sharma13 March 2024 5:30 PM ISTEmcure Pharmaceuticals will exclusively distribute and promote the Company's Cardiovascular range of products that include well-established brands...
Exercise Caution: Meta-analysis reports significant prevalence of bleeding after PCI Medha Baranwal13 March 2024 6:15 AM ISTIran: A systematic review and meta-analysis has shown that the incidence of bleeding after PCI is 4.4 %, which is a significant result. The findings,...
COVID jab linked to lower risk of COVID-19-related clot and heart complications: Study Dr. Kamal Kant Kohli13 March 2024 6:00 AM ISTThe risk of cardiac and clot-related complications following COVID-19 is substantially reduced in people who receive the COVID-19 vaccination compared...
Research reveals the liver's immune system consumes the "bad cholesterol" Anshika Mishra13 March 2024 5:30 AM ISTSweden: In a study, published in the Journal Nature Cardiovascular Research, researchers from Karolinska Institute in Sweden revealed that immune...
Iron deficiency common and tied to adverse outcomes in patients with HF with reduced EF: Study Medha Baranwal12 March 2024 7:45 AM ISTIndia: A recent study published in Cureus has shed light on iron deficiency, a silent threat in patients with heart failure with reduced ejection...
Researchers demonstrate that viral infections present early risks to the heart Anshika Mishra12 March 2024 7:00 AM ISTA new study led by James Smyth, associate professor at the Fralin Biomedical Research Institute, has revealed insights into fatal viral infections...
High cholesterol twice as prevalent among American Indian teens and young adults, reveals study Dr. Kamal Kant Kohli11 March 2024 1:15 AM ISTYoung American Indians, ages 15-39, had cholesterol levels more than two times higher than the general U.S. population, according to new research...
FDA approves semaglutide for major heart disease prevention among obese Dr. Kamal Kant Kohli10 March 2024 9:15 PM ISTThe US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in...
P2Y12 inhibitor monotherapy after 3 months of DAPT noninferior to 12 months of DAPT after PCI: JAMA Medha Baranwal10 March 2024 8:30 PM ISTSouth Korea: P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) is not inferior to 12-month DAPT in patients with coronary...
Lupin Digital Health CEO Sidharth Srinivasan Explores the Transformative Impact of Digital Therapeutics MD Bureau9 March 2024 9:23 PM ISTIndia Live 2024 , the paramount global cardiology event hosted by the Interventional Cardiology Foundation of India, focused on Interventional...
Novo Nordisk Wegovy gets USFDA nod for lowering heart risks Ruchika Sharma9 March 2024 2:30 PM ISTDenmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a...
CAC score predicts heart attacks, strokes in patients with stable chest pain: Study Dr. Kamal Kant Kohli9 March 2024 3:00 AM ISTGermany: A recent study published in Radiology revealed that coronary artery calcium (CAC) scoring with CT can identify symptomatic patients with a...
